97 related articles for article (PubMed ID: 2568975)
1. Influence of lactate on isoproterenol-induced lipolysis and beta-adrenoceptors distribution in human fat cells.
De Pergola G; Cignarelli M; Nardelli G; Garruti G; Corso M; Di Paolo S; Cardone F; Giorgino R
Horm Metab Res; 1989 Apr; 21(4):210-3. PubMed ID: 2568975
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species.
Langin D; Portillo MP; Saulnier-Blache JS; Lafontan M
Eur J Pharmacol; 1991 Jul; 199(3):291-301. PubMed ID: 1680716
[TBL] [Abstract][Full Text] [Related]
3. A reliable assay for beta-adrenoceptors in intact isolated human fat cells with a hydrophilic radioligand, [3H]CGP-12177.
Lacasa D; Mauriège P; Lafontan M; Berlan M; Giudicelli Y
J Lipid Res; 1986 Apr; 27(4):368-76. PubMed ID: 2873196
[TBL] [Abstract][Full Text] [Related]
4. Human fat cell beta-adrenergic receptors: beta-agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta 1-antagonists.
Mauriège P; De Pergola G; Berlan M; Lafontan M
J Lipid Res; 1988 May; 29(5):587-601. PubMed ID: 2900871
[TBL] [Abstract][Full Text] [Related]
5. Testosterone increases lipolysis and the number of beta-adrenoceptors in male rat adipocytes.
Xu XF; De Pergola G; Björntorp P
Endocrinology; 1991 Jan; 128(1):379-82. PubMed ID: 1846106
[TBL] [Abstract][Full Text] [Related]
6. The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.
Tavernier G; Galitzky J; Bousquet-Melou A; Montastruc JL; Berlan M
J Pharmacol Exp Ther; 1992 Dec; 263(3):1083-90. PubMed ID: 1361569
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of surface beta-adrenoceptors on intact human mononuclear leukocytes. Time-course and isoproterenol concentration dependence.
Sandnes D; Gjerde I; Refsnes M; Jacobsen S
Biochem Pharmacol; 1987 Apr; 36(8):1303-11. PubMed ID: 3036165
[TBL] [Abstract][Full Text] [Related]
8. Species and strain-related differences in the expression and functionality of beta-adrenoceptor subtypes in adipose tissue.
Van Liefde I; Van Ermen A; van Witzenburg A; Fraeyman N; Vauquelin G
Arch Int Pharmacodyn Ther; 1994; 327(1):69-86. PubMed ID: 7944829
[TBL] [Abstract][Full Text] [Related]
9. Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits.
Langin D; Portillo M; Dauzats M; Lafontan M
Endocrinology; 1992 Jan; 130(1):307-15. PubMed ID: 1309335
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P
J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
[TBL] [Abstract][Full Text] [Related]
11. D-(-)-beta-hydroxybutyrate inhibits catecholamine-stimulated lipolysis and decreases beta-adrenoceptors' affinity in human fat cells but not in lymphomonocytes.
De Pergola G; Cignarelli M; Corso M; Garruti G; Di Paolo S; Giorgino R
Acta Endocrinol (Copenh); 1990 Apr; 122(4):450-4. PubMed ID: 2159203
[TBL] [Abstract][Full Text] [Related]
12. Agonist and antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes.
Shimizu M; Blaak EE; Lonnqvist F; Gafvels ME; Arner P
Pharmacol Toxicol; 1996 Apr; 78(4):254-63. PubMed ID: 8861784
[TBL] [Abstract][Full Text] [Related]
13. Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells.
Engfeldt P; Hellmér J; Wahrenberg H; Arner P
J Biol Chem; 1988 Oct; 263(30):15553-60. PubMed ID: 2844816
[TBL] [Abstract][Full Text] [Related]
14. Irreversible antagonism of beta-adrenoceptors with para-amino-benzyl-carazolol provides further evidence for an atypical rat adipocyte beta-adrenoceptor.
Bojanic D; Nahorski SR
J Recept Res; 1984; 4(1-6):21-35. PubMed ID: 6098653
[TBL] [Abstract][Full Text] [Related]
15. Evidence that epinephrine acts preferentially as an antilipolytic agent in abdominal human subcutaneous fat cells: assessment by analysis of beta and alpha 2 adrenoceptor properties.
Berlan M; Lafontan M
Eur J Clin Invest; 1985 Dec; 15(6):341-8. PubMed ID: 3007159
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
Carpéné C; Galitzky J; Collon P; Esclapez F; Dauzats M; Lafontan M
J Pharmacol Exp Ther; 1993 Apr; 265(1):237-47. PubMed ID: 8097243
[TBL] [Abstract][Full Text] [Related]
17. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
[TBL] [Abstract][Full Text] [Related]
18. Direct assessment of beta-adrenergic receptors in intact rat adipocytes by binding of [3H]CGP 12177. Evidence for agonist high-affinity binding complex and for beta 1 and beta 2 receptor subtypes.
Lacasa D; Agli B; Giudicelli Y
Eur J Biochem; 1985 Jan; 146(2):339-46. PubMed ID: 2981688
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone treatment of hypophysectomized rats increases catecholamine-induced lipolysis and the number of beta-adrenergic receptors in adipocytes: no differences in the effects of growth hormone on different fat depots.
Yang S; Björntorp P; Liu X; Edén S
Obes Res; 1996 Sep; 4(5):471-8. PubMed ID: 8885212
[TBL] [Abstract][Full Text] [Related]
20. Predominance of beta 3-adrenergic component in catecholamine activation of lipolysis in garden dormouse adipocytes.
Carpéné C; Ambid L; Lafontan M
Am J Physiol; 1994 Mar; 266(3 Pt 2):R896-904. PubMed ID: 7909204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
